• About us
• Contact

Advertisement

Organisation › Details

Novacyt (Group)

The Novacyt Group is a leader in the field of diagnostics with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NovaPrep®, and a strong international network provided by Lab21, its UK diagnostics subsidiary, it is able to provide an extensive range of oncology and infectious disease products globally. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its customers and partners include major corporates. *

 

	Start	2006-07-11 established
	Industry	laboratory equipment and instruments
	Industry 2	diagnostics (medical/biological)
	Person	Allmond, David (Novacyt 202110 CEO before Amryt Pharma + Amgen + Celgene + Aegerion Pharmaceuticals)
	Person 2	Wakefield, James (Novacyt 201704 Board Chairman)
	Region	Paris
	Country	France
	Street	13 Avenue Morane Saulnier
	City	78140 Vélizy-Villacoublay
	Tel	+33-1-3946-5104
		Address record changed: 2020-12-02
Basic data	Employees	D: 101 to 500 (2017-12-31)
	Currency	EUR
	Annual sales	14,954,000 (revenue, consolidated (2017) 2017-12-31)
	Profit	-5,442,000 (2017-12-31)
	Cash	4,300,000 (2017-12-31)
		* Document for »About Section«:
		Record changed: 2024-02-12

Advertisement

More documents for Novacyt (Group)

• [1] Novacyt S.A.. (7/3/23). "Press Release: Recommended Cash Offer. Novacyt UK Holdings Limited  (a wholly-owned subsidiary of Novacyt S.A.) for Yourgene Health plc [ RESTRICTED]"....
• [2] Novacyt S.A.. (7/29/21). "Press Release: David Allmond Announced as CEO Following Decision by Graham Mullis to Retire". Paris & Camberley....
• [3] Novacyt S.A.. (1/5/21). "Press Release: Executive Management and Proposed Board Changes". Paris & Camberley....
• [4] Novacyt S.A.. (9/26/18). "Press Release: Novacyt Half Year 2018 Results. Molecular Product Revenues up 18% to €3m – Gross Margin Increases to 64%". Paris & Camberley....
• [5] Novacyt S.A.. (9/13/18). "Press Release: Novacyt Partners with Applied Microarrays in Assay Design". Paris & Camberley....
• [6] Novacyt S.A.. (4/26/18). "Press Release: Novacyt Full Year 2017 Results". Paris & Camberley....
• [7] Novacyt S.A.. (10/18/17). "Press Release: Proposed Admission to Trading on AIM and Successful Capital Riase of €9.7 Million [Not for US, AU, CA, JP or ZA or any other jurisdiction where unlawful]". Paris & Cambridge....
• [8] Novacyt S.A.. (7/20/17). "Press Release: Novacyt Revenues Half Year 2017". Paris & Cambridge....
• [9] Novacyt S.A.. (6/20/17). "Press Release: Novacyt Successfully Completes €3.0M Fundraising". Paris & Cambridge....
• [10] Novacyt S.A.. (4/27/17). "Press Release: Novacyt Full Year 2016 Results". Paris & Cambridge....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.